Strengths and prices
| Strength | Price per vial | Availability | Batch | |
|---|---|---|---|---|
| 5 mg | $15.00 | Out of stock | — | |
| 10 mg | $20.00 | In stock | SK-2607-0024 |
Every vial carries its batch code and a QR that opens the certificate of analysis for that exact batch. No account is needed to read one.
What it is
Selank is a synthetic heptapeptide: the immune peptide tuftsin (Thr-Lys-Pro-Arg) extended by Pro-Gly-Pro. It was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences.
Identity
| Type | Synthetic peptide, 7 amino acids |
|---|---|
| Sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro |
| Molecular formula | C33H57N11O9 |
| Molecular weight | 751.9 g/mol |
| CAS number | 129954-34-3 |
| PubChem CID | 11765600 |
Selank is a synthetic linear heptapeptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro: tuftsin (Thr-Lys-Pro-Arg) extended at the C-terminus by Pro-Gly-Pro. Molecular formula C33H57N11O9, molecular weight 751.9 g/mol (PubChem CID 11765600, CAS 129954-34-3). It has a free N-terminus and C-terminus and contains no cysteine, methionine or aromatic residue. Three of its seven residues are proline, and its lysine and arginine make it a basic, water-soluble peptide. Mass spectrometry confirms the intact mass, which distinguishes it from shorter fragments such as tuftsin itself, and HPLC reports purity. It is supplied as a white lyophilized powder in a sealed vial.
What the published research covers
Most of the published work is Russian, in rodents and in small clinical studies. It is a registered medicine in Russia.
Selank was designed in Moscow at the Institute of Molecular Genetics of the Russian Academy of Sciences, in the same line of work that produced Semax. Its starting point is tuftsin, Thr-Lys-Pro-Arg, a tetrapeptide fragment of the heavy chain of immunoglobulin G with immune-stimulating activity. Its designers added the C-terminal tripeptide Pro-Gly-Pro, which also slows the breakdown of Semax by peptidases. It is a registered medicine in Russia and is not approved elsewhere.
Early mechanistic work measured the breakdown of enkephalins. In blood from patients with generalized anxiety disorder, the half-life of enkephalin was shorter than normal, and Selank inhibited the plasma enzymes that degrade enkephalin, with a half-maximal inhibitory concentration of 15 micromolar (Zozulya, 2001). In rats, a gene-expression study found that Selank changed the expression of 45 of 84 neurotransmission genes in the frontal cortex one hour after administration, with changes that correlated with those caused by GABA, which the authors read as a possible allosteric action on the GABA system (Volkova, 2016). In a rat model of unpredictable chronic mild stress, the same group compared Selank, diazepam and the two together in the elevated plus maze and reported that the combination gave anxiety measures closest to those before stress (Kasian, 2017). The clinical reports are Russian and published in Russian. A 2008 study compared Selank in 30 patients with medazepam in 32 patients with generalized anxiety disorder or neurasthenia, using the Hamilton and Zung scales, and reported similar anxiolytic effects along with changes in serum enkephalin activity (Zozulia, 2008). A 2014 study of 60 patients with anxiety and somatoform disorders compared it with phenazepam (Medvedev, 2014).
Nearly all of this work comes from Russian groups connected with the developers, with few independent English-language replications. The clinical studies are small and compared Selank with another anxiolytic, and they are not reported to the design standards of a registration trial. The mechanism is unresolved: inhibition of enkephalin breakdown, effects on GABA-related gene expression and immune effects inherited from tuftsin have each been proposed.
Regulatory status
Registered in Russia. Not approved by the FDA for any use. Supplied for laboratory research only.
Testing and documentation
Identity is confirmed by mass spectrometry and purity by HPLC. The certificate of analysis for the batch is reachable from the code on the vial.
Questions laboratories ask
- What strengths is Selank offered in?
- Vials of 5 mg and 10 mg, as listed on the product page. The amount is on the vial label and on the certificate of analysis for the batch.
- Is this the medicine registered in Russia?
- No. A Russian pharmaceutical product exists under this name; this material is a research peptide of the same sequence, supplied for laboratory research only and not approved by the FDA for any use.
- How is Selank related to Semax?
- Both were developed at the Institute of Molecular Genetics in Moscow, and both end in the tripeptide Pro-Gly-Pro. Selank is built on tuftsin, a fragment of immunoglobulin G; Semax is built on a fragment of ACTH.
- How is a batch tested?
- By an independent laboratory: identity by mass spectrometry and purity by HPLC. The QR code on the vial opens the certificate of analysis for that exact batch; no account is needed to read it.
- Who can order, and how does it ship?
- Orders are accepted under the Research Use Agreement, reaffirmed with every order. Orders ship from Montana, the next business day when paid by card, to United States addresses only and not to freight forwarders.
References
- Zozulya AA et al. (2001). The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity. Bulletin of Experimental Biology and Medicine. PubMed 11550013
- Zozulia AA et al. (2008). Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. PubMed 18454096
- Medvedev VE et al. (2014). A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. PubMed 25176261
- Volkova A et al. (2016). Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Frontiers in Pharmacology. PubMed 26924987
- Kasian A et al. (2017). Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats. Behavioural Neurology. PubMed 28280289
How it ships
Ordering
Ordering needs an account. A retail account opens as soon as you request it and costs nothing. You pay by card at checkout, or by invoice before the order ships. A wholesale account is reviewed before it opens.
Research use only
This product is a research chemical sold solely for in-vitro laboratory research by qualified persons. It is not a drug, food, supplement or cosmetic, has not been evaluated by the FDA, and must not be administered to any person or animal. Read the full agreement